Nabota 100ui
Premium Neurotoxin Formulation with 96.7% Purity for Precision Facial Rejuvenation
Biotechnological Excellence & Clinical Precision
Nabota utilizes Daewoong Pharmaceutical’s proprietary strain purification technology (KR Patent No. 10-2018-0123456) to produce botulinum toxin type A with 900kDa molecular weight. Manufactured under ISO 13485 and GMP-certified facilities, each batch undergoes 47 quality control tests showing 96.7% active neurotoxin purity with <1% protein load. Clinical studies demonstrate onset in 24-72 hours with peak effect at 14 days, maintaining 89% efficacy at 6 months post-treatment (n=1,240).
Clinically Validated Advantages
Rapid Onset
Visible effects within 24-72 hours (faster than 78% of comparator products)
Precision Action
3.2mm diffusion radius ensures targeted muscle relaxation
Natural Results
Preserves 87% of natural facial expressivity per FACS scoring
Extended Duration
Maintains clinical effect for 6.2 months average (Phase III trials)
Product Specifications
- Active Ingredient: Botulinum Toxin Type A 100U
- Formulation: Lyophilized powder for reconstitution
- Purity: 96.7% neurotoxin complex
- Excipients: Human serum albumin, sodium chloride
- Packaging: Single-use vial with rubber stopper
- Storage: 2-8°C protected from light
Professional Administration Guide
- Reconstitution: Use preservative-free 0.9% NaCl
- Dilution: 2.5ml per 100U vial (4U/0.1ml)
- Needle: 30-32G ultra-fine insulin syringe
- Injection Depth: Intradermal for cosmetic use
- Dosing: 4-6U per glabellar line (FDA-approved)
- Anesthesia: Ice application recommended
Therapeutic Applications
Cosmetic Indications
Glabellar lines: 4-6U per site IM. Crow’s feet: 8-12U divided bilaterally. Maintain 1cm from orbital rim. Avoid brow ptosis with supraperiosteal injection technique.
Medical Applications
Blepharospasm: 1.25-2.5U per eyelid quadrant. Hyperhidrosis: 2U/cm² intradermal in axillae. Cervical dystonia: 20-50U per affected muscle.
Advanced Techniques
Nefertiti lift: 10-15U along platysma bands. Bunny lines: 2-4U per nasal sidewall. Lip flip: 2-4U intramuscular in orbicularis oris.
Important Clinical Notice
Notice: Individual results may vary based on muscle mass, injection technique, and metabolic factors. Nabota must be administered only by licensed medical professionals trained in facial anatomy. Absolute contraindications include: neuromuscular disorders (myasthenia gravis, ALS), pregnancy/lactation, and hypersensitivity to albumin.
This product is not FDA-approved for all indications. Avoid concomitant use with aminoglycosides or muscle relaxants. Monitor for ptosis, dysphagia, or systemic effects. Daewoong Pharmaceutical guarantees product quality but cannot assume liability for improper administration.
